Published in Women's Health Weekly, May 15th, 2006
In this case, brought by R2, iCAD's competitor alleged that iCAD infringed two R2 patents. A panel of three experienced arbitrators rejected all of R2's claims, finding that iCAD did not infringe any patent asserted by R2.
In response to the arbitration commenced by R2, iCAD asserted in a counterclaim that R2 infringed several iCAD patents. The arbitrators found that R2 did not infringe on those patents.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.